| Bill | S 660 |
|---|---|
| Type of Legislation | Senate Bill |
| Congress | 116 |
| Source | View original on Congress.gov |
Geographic Scope
National
Description
Efficiency and Transparency in Petitions Act
This bill requires a petition regarding a pending generic drug or biological product application to be submitted to the Food and Drug Administration (FDA) within one year of when the petitioner discovers the issue that is the basis for the petition.
The FDA may grant a waiver of the one-year deadline.
Bill Title
Efficiency and Transparency in Petitions Act
Linked Goals
Steps
- 2019-03-05: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2019-03-05: Introduced in Senate
Projected Outcome
A more informed proposal or public response aligned with the Promote General Welfare goal.